Advanced search×

Current Diabetes Reports

Print ISSN
Electronic ISSN
Impact factor
Usage rank
Article count
Free count
Free percentage
PDFs via platforms
Metapress, Gale, and Springer

  1. Pathogenesis of pain in peripheral diabetic neuropathy.

    Current Diabetes Reports 7(6):429 (2007) PMID 18255005

    Recent advances in understanding the pain associated with diabetic neuropathy are likely to provide significant mechanistic insights and offer better therapies. In clinical research, new tools for measuring neuropathic pain and validation of histologic and other biomarkers will provide the found...
  2. Contrast-induced nephropathy: update with special emphasis on patients with diabetes.

    Current Diabetes Reports 7(6):454 (2007) PMID 18255010

    Contrast-induced nephropathy (CIN) continues to be a significant complication of the increasing use of iodinated contrast media. There have been few new insights into pathogenesis; despite multiple strategies aimed at prophylaxis, very few have proven efficacious. This article reviews our curren...
  3. Microangiopathy in older patients with diabetes mellitus.

    Current Diabetes Reports 7(6):437 (2007) PMID 18255006

  4. Topical treatment for painful diabetic neuropathy?

    Current Diabetes Reports 7(6):407 (2007) PMID 18255000

  5. Temperature monitoring to assess, predict, and prevent diabetic foot complications.

    Current Diabetes Reports 7(6):416 (2007) PMID 18255002

    Preventing foot complications in high-risk patients with diabetes is often overlooked. Assessing risk factors and providing standard preventative care is low tech and relatively inexpensive. The objective of this article is to discuss standard screening and prevention practices and using tempera...
  6. Statin therapy in renal disease: harmful or protective?

    Current Diabetes Reports 7(6):467 (2007) PMID 18255012

    Chronic kidney disease (CKD) creates one of the highest-risk atherosclerotic states that can occur in human beings. The use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) has gained widespread acceptance in the general population for the purposes of lowering low-density ...
  7. Targeting skeletal muscle AMP-activated protein kinase to treat type 2 diabetes.

    Current Diabetes Reports 7(6):399 (2007) PMID 18254999

  8. The step-by-step program for reducing diabetic foot problems: a model for the developing world.

    Current Diabetes Reports 7(6):425 (2007) PMID 18255004

    The prevalence of diabetes is increasing globally, particularly in the developing world. The diabetic foot is one of the most devastating chronic complications of diabetes. The Step-by-Step project was initiated in India, with participation from neighboring countries and Tanzania, to improve dia...
  9. Neuropathy associated with prediabetes: what is new in 2007?

    Current Diabetes Reports 7(6):420 (2007) PMID 18255003

    Length-dependent polyneuropathy has long been recognized as a frequent complication of diabetes. A decade of observational and epidemiologic studies support the concept that intermittent hyperglycemia or insulin resistance associated with prediabetes may be sufficient to damage distal nerves. Fe...
  10. Examining diabetic nephropathy through the lens of mouse genetics.

    Current Diabetes Reports 7(6):459 (2007) PMID 18255011

    Although diabetic nephropathy occurs in only a minority of patients with diabetes, it is the major cause of end-stage renal disease in the United States. Hyperglycemia and hypertension are important factors predisposing patients to diabetic nephropathy, but accumulating evidence points to critic...